🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/05/2015 6,18 6,30 6,12 6,26 +1,62% 2,91% 658.500
21/05/2015 6,15 6,31 6,12 6,16 +0,33% 3,09% 541.800
20/05/2015 6,07 6,24 6,02 6,14 +0,99% 3,62% 602.200
19/05/2015 6,15 6,24 6,05 6,08 -1,62% 3,09% 864.200
18/05/2015 6,26 6,32 6,10 6,18 -1,75% 3,51% 1.053.900
15/05/2015 6,31 6,36 6,16 6,29 -0,32% 3,09% 721.600
14/05/2015 6,19 6,38 5,99 6,31 +2,27% 6,30% 1.270.200
13/05/2015 6,39 6,39 6,00 6,17 -1,59% 6,10% 2.511.900
12/05/2015 6,44 6,76 6,26 6,27 -6,28% 7,76% 3.276.800
11/05/2015 7,04 7,10 6,67 6,69 -4,97% 6,11% 2.297.000
08/05/2015 6,94 7,05 6,75 7,04 +2,62% 4,32% 1.876.500
07/05/2015 6,87 7,00 6,73 6,86 -0,15% 3,93% 919.800
06/05/2015 6,99 6,99 6,80 6,87 -0,87% 2,72% 663.300
05/05/2015 7,01 7,02 6,85 6,93 -0,14% 2,43% 682.100
04/05/2015 7,01 7,19 6,92 6,94 -0,43% 3,85% 802.000
01/05/2015 6,95 7,01 6,85 6,97 +1,01% 2,30% 814.000
30/04/2015 7,02 7,15 6,78 6,90 -1,85% 5,34% 1.271.700
29/04/2015 6,90 7,16 6,77 7,03 +1,15% 5,65% 897.200
28/04/2015 7,03 7,18 6,81 6,95 -1,42% 5,26% 926.400
27/04/2015 7,28 7,37 6,88 7,05 -3,16% 6,73% 1.373.500
24/04/2015 7,25 7,41 7,18 7,28 +0,69% 3,17% 922.400
23/04/2015 7,10 7,39 7,05 7,23 +5,16% 4,79% 1.775.400
22/04/2015 6,77 7,10 6,62 6,88 +2,00% 7,09% 1.418.600
21/04/2015 7,00 7,01 6,66 6,74 -3,02% 4,93% 1.473.300
20/04/2015 7,10 7,13 6,88 6,95 -1,84% 3,56% 1.090.400
17/04/2015 7,03 7,12 6,84 7,08 -0,42% 3,91% 1.456.100
16/04/2015 7,15 7,30 7,03 7,11 +0,28% 3,78% 1.771.800
15/04/2015 7,41 7,50 7,02 7,09 -3,93% 6,48% 3.345.500
14/04/2015 7,47 7,74 7,35 7,38 -7,75% 5,22% 3.063.000
13/04/2015 8,75 8,90 7,95 8,00 +1,14% 10,86% 8.550.900